- Home
- HIMS vs ALGN Comparison
HIMS vs ALGN Comparison
Compare HIMS & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIMS
- ALGN
- Stock Information
- Founded
- HIMS 2017
- ALGN 1997
- Country
- HIMS United States
- ALGN United States
- Employees
- HIMS N/A
- ALGN N/A
- Industry
- HIMS Medical/Nursing Services
- ALGN Industrial Specialties
- Sector
- HIMS Health Care
- ALGN Health Care
- Exchange
- HIMS Nasdaq
- ALGN Nasdaq
- Market Cap
- HIMS 10.8B
- ALGN 12.5B
- IPO Year
- HIMS N/A
- ALGN N/A
- Fundamental
- Price
- HIMS $56.17
- ALGN $132.57
- Analyst Decision
- HIMS Hold
- ALGN Buy
- Analyst Count
- HIMS 11
- ALGN 13
- Target Price
- HIMS $37.20
- ALGN $216.25
- AVG Volume (30 Days)
- HIMS 28.3M
- ALGN 1.2M
- Earning Date
- HIMS 11-03-2025
- ALGN 10-22-2025
- Dividend Yield
- HIMS N/A
- ALGN N/A
- EPS Growth
- HIMS 866.21
- ALGN 0.42
- EPS
- HIMS 0.79
- ALGN 5.92
- Revenue
- HIMS $2,013,538,000.00
- ALGN $3,964,802,000.00
- Revenue This Year
- HIMS $61.80
- ALGN $2.03
- Revenue Next Year
- HIMS $19.38
- ALGN $3.31
- P/E Ratio
- HIMS $71.21
- ALGN $22.39
- Revenue Growth
- HIMS 88.69
- ALGN 0.56
- 52 Week Low
- HIMS $15.73
- ALGN $127.70
- 52 Week High
- HIMS $72.98
- ALGN $262.87
- Technical
- Relative Strength Index (RSI)
- HIMS 61.73
- ALGN 39.89
- Support Level
- HIMS $48.69
- ALGN $128.52
- Resistance Level
- HIMS $56.52
- ALGN $134.82
- Average True Range (ATR)
- HIMS 3.44
- ALGN 4.24
- MACD
- HIMS 1.11
- ALGN 0.68
- Stochastic Oscillator
- HIMS 97.78
- ALGN 27.44
About HIMS Hims & Hers Health Inc.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
About ALGN Align Technology Inc.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.